Pandemic linked to 16% rise in babies born with heart defects

Can't see this email? View it online

	Cardiology
	The latest cardiology news from News Medical

	Pandemic linked to 16% rise in babies born with heart defects The proportion of babies born with a congenital heart abnormality increased by 16 per cent after the first year of the pandemic, according to research at City St George's, University of London and published today in Ultrasound in Obstetrics and Gynecology.

	Drinking non-fermented milk may increase the risk of heart disease in women The study suggests non-fermented milk may raise ischemic heart disease risk in women, urging a closer look at dairy consumption and its health impacts.

			AI-based video system may offer quick, no-contact screenings for high blood pressure and diabetes A new system that combines high-speed video and an artificial intelligence (AI)-powered algorithm may offer quick, no-contact screenings for high blood pressure and Type 1 or Type 2 diabetes without needing blood tests, blood pressure cuffs or expensive wearable devices, according to a preliminary study to be presented at the American Heart Association's Scientific Sessions 2024.

			BMI's influence on disease pathogenesis uncovered in new research The study highlights BMI's role in mediating genetic risk for diseases, suggesting a complex relationship with conditions like heart failure and osteoarthritis.

			Update on diagnosis, risk classification and treatment of Kawasaki Disease Advances in cardiac imaging techniques and risk categorization have led to improvements in diagnosis, initial treatment and long-term management of patients with Kawasaki Disease, according to a new scientific statement published today in the American Heart Association's flagship, peer-reviewed journal Circulation.

	Common heart failure drug reduces risk of chemotherapy-induced heart damage in cancer patients A commonly prescribed medication for heart failure was linked to a lower risk of heart damage, or cardiotoxicity, among high-risk cancer patients undergoing chemotherapy treatment using anthracyclines, according to preliminary late-breaking science presented today at the American Heart Association's Scientific Sessions 2024.

	Study suggests beta-blockers may elevate depression symptoms in post-MI patients In MI patients with preserved heart function, beta-blockers are linked to higher depressive symptoms, indicating a need for careful mental health assessment.

	Electronic nudges boost flu vaccination rates among heart attack survivors An electronic letter, or nudge, highlighting the cardiovascular benefits of influenza vaccines improved vaccination rates among more than 2 million adults—with a greater impact on those who have had a heart attack—across three clinical trials spanning the most-recent, two consecutive influenza seasons in Denmark.

	What is Cardiofaciocutaneous Syndrome? Cardiofaciocutaneous syndrome is a rare genetic disorder caused by RAS/MAPK mutations, leading to congenital heart issues and various developmental delays.

	Intravenous infusion of exenatide fails to reduce risks of complications in heart surgery patients A large-scale clinical trial found that intravenous infusion of exenatide, a glucagon-like peptide-1 (GLP-1) analog medication, during heart surgeries involving bypass did not significantly reduce the risk of death, stroke or organ failure.

	Excessive sedentary time linked to higher heart disease risk More time spent sitting, reclining or lying down during the day may increase the risk of cardiovascular disease (CVD) and death, according to a study in JACC, the flagship journal of the American College of Cardiology, and presented at the American Heart Association's Scientific Sessions 2024.

	AI program enhances echocardiogram interpretation and reduces wait times Using an artificial intelligence program to read echocardiograms may reduce the wait time for results and help lead to more timely medical care, according to late-breaking science presented today at the American Heart Association's Scientific Sessions 2024.

	Anti-obesity drugs show promise in improving cardiovascular health beyond weight loss Popular anti-obesity drugs continue to show cardiovascular benefits beyond weight loss, according to several new papers published in JACC, the flagship journal of the American College of Cardiology, that are being simultaneously presented at the American Heart Association's 2024 Scientific Sessions.

	Benefits of sport and leisure activities outweigh the risks for people with heart disease, cardiologists say While exercise is generally beneficial for a person's overall health, physical activities may increase the risk of adverse cardiovascular disease events in certain susceptible individuals. However, cardiologists say that the benefits outweigh the risks.

Website: www.news-medical.net

Email: [email protected]

Telephone: +44 (0)161 457 7150

AZoNetwork UK Ltd.
NEO, 4th Floor
9 Charlotte Street, Manchester
M1 4ET, UK

Why did you receive this email?
You recently requested related information from us and asked to be notified of additional information.

Not interested anymore?
Unsubscribe or
Update Your Newsletter Subscriptions